Assessment of Antibody-producing Capacity in Man [Abstract] (DX 174 is a highly immunogenic bacteriophage which can be used to measure the capacity for antibody-production in man. The results of intravenous immunization in 26 normal adults have already been described (Peacock et al. 1973).
retain their permissiveness for other viruses, indicating that their altered behaviour towards herpes simplex virus is determined by immunological factors. This specificity makes it unlikely that interferon accounts for the acquired resistance to herpes simplex infection -a conclusion supported by measurement of interferon secreted into these cultures which lags considerably behind the inactivation of herpes simplex virus. The altered behaviour of lymphocyte cultures towards virus replication can be readily applied to the search for a viral etiology in diseases where an infectious agent is not immediately apparent.
Moreover, the sensitivity of semi-micro plaque assays (Rager-Zisman & Merigan 1973) , allied to their reproducibility (Fig 2) , have simplified the clinical use of such techniques.
Considerable attention has been given to the possibility that cell-mediated immunity operates through cytotoxic reactions against virus-infected cells (Porter 1971) . To this end, several assays have been devised for measuring the ability of blood lymphocytes and other mononuclear cells to release 51Cr from virus-infected target cells (Steele et al. 1973) . In principle, combinations of virus strain and host cells are employed which allow the expression of virus-specific antigens on the cell membrane, but which produce only a slow cytopathic effect.. Particularly noteworthy are cytotoxic reactions by sensitized lymphocytes against cells infected with measles or rubella virus. Such techniques help in the interpretation of a number of puzzling phenomena in human immunopathology. For example, the atypical cells in the blood of patients with infectious mononucleosis show spontaneous and efficient cytotoxicity against lymphoblastoid cell lines with surface antigens coded by EB virus (Denman & Pelton 1974) . Nevertheless, firm evidence is lacking that cell-mediated immunity operates in vivo against infected cells rather than directly to inactivate infectious virions in the blood or other extracellular compartments.
The interactions between virus and lymphoid cells are complicated by the variable ability of these cells to support virus replication. Furthermore, the in vivo relevance of many of these reactions remains unproven. Nevertheless, it is already clear that in vitro techniques are availaable for assessing many of the pathways and cooperative mechanisms which constitute cellmediated immunity to virus infections in man. 
